Matt Nelson | Head, Genetics
GSK

Matt Nelson, Head, Genetics, GSK

Appearances:



BioData West: Day 2 @ 14:00

The genetics of drug efficacy: opportunities and challenges

  • How efficacy has become the most common cause of attrition in late-phase drug development
  • Driving the application of efficacy pharmacogenetics into drug discovery and development across industry
  • Defining the value of routine, early and cumulative screening for genetic predictors of efficacy, as an integrated component of clinical trial analysis

back to speakers